Tilray Brands Inc. [TLRY] Is Currently 2.21 below its 200 Period Moving Avg: What Does This Mean?

Tilray Brands Inc. [NASDAQ: TLRY] traded at a high on 03/03/23, posting a 2.21 gain after which it closed the day’ session at $2.77. The company report on March 1, 2023 that Potently Canadian Cannabis Brand, CANACA, Introduces New Collection of Terpene Rich Products Across Canada.


From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".

Sponsored


Following the release of its signature #FEELTHEBOOST BHO-infused products; with a spotlight on Shredded Weedies™, Crumble Cones™ and Indica 30’s, CANACA returns with Bursts and Darts, providing a range of products formulated to embrace personalized consumer convenience.

The results of the trading session contributed to over 10806090 shares changing hands. Over the past one week, the price volatility of Tilray Brands Inc. stands at 3.30% while the volatility over the past one month is 4.77%.

The market cap for TLRY stock reached $1.67 billion, with 611.71 million shares outstanding and 609.49 million shares in the current float. Compared to the average trading volume of 18.24M shares, TLRY reached a trading volume of 10806090 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Tilray Brands Inc. [TLRY]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TLRY shares is $4.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TLRY stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Bernstein have made an estimate for Tilray Brands Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on November 02, 2022. The new note on the price target was released on July 29, 2022, representing the official price target for Tilray Brands Inc. stock. Previously, the target price had yet another raise to $9, while Canaccord Genuity analysts kept a Buy rating on TLRY stock.

The Average True Range (ATR) for Tilray Brands Inc. is set at 0.14, with the Price to Sales ratio for TLRY stock in the period of the last 12 months amounting to 2.78. The Price to Book ratio for the last quarter was 0.38, with the Price to Cash per share for the same quarter was set at 0.72.

How has TLRY stock performed recently?

Tilray Brands Inc. [TLRY] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.77. With this latest performance, TLRY shares dropped by -16.82% in over the last four-week period, additionally sinking by -27.11% over the last 6 months – not to mention a drop of -52.49% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TLRY stock in for the last two-week period is set at 42.13, with the RSI for the last a single of trading hit 40.96, and the three-weeks RSI is set at 43.37 for Tilray Brands Inc. [TLRY]. The present Moving Average for the last 50 days of trading for this stock 2.96, while it was recorded at 2.76 for the last single week of trading, and 3.46 for the last 200 days.

Tilray Brands Inc. [TLRY]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Tilray Brands Inc. [TLRY] shares currently have an operating margin of -36.48 and a Gross Margin at +0.26. Tilray Brands Inc.’s Net Margin is presently recorded at -75.88.

Return on Equity for this stock declined to -10.77, with Return on Assets sitting at -8.31.

Tilray Brands Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.90.

Insider trade positions for Tilray Brands Inc. [TLRY]

There are presently around $188 million, or 12.50% of TLRY stock, in the hands of institutional investors. The top three institutional holders of TLRY stocks are: ETF MANAGERS GROUP, LLC with ownership of 7,862,260, which is approximately -5.889% of the company’s market cap and around 1.40% of the total institutional ownership; SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 4,164,604 shares of the stock with an approximate value of $11.54 million in TLRY stocks shares; and MORGAN STANLEY, currently with $7.13 million in TLRY stock with ownership of nearly -33.42% of the company’s market capitalization.

Positions in Tilray Brands Inc. stocks held by institutional investors increased at the end of Wednesday and at the time of the Wednesday reporting period, where 161 institutional holders increased their position in Tilray Brands Inc. [NASDAQ:TLRY] by around 12,632,811 shares. Additionally, 131 investors decreased positions by around 16,228,824 shares, while 115 investors held positions by with 38,896,970 shares. The mentioned changes placed institutional holdings at 67,758,605 shares, according to the latest SEC report filing. TLRY stock had 65 new institutional investments in for a total of 4,782,703 shares, while 48 institutional investors sold positions of 1,208,323 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here